A PHASE 2B, RANDOMIZED, CONTROLLED, OBSERVER-BLIND, MULTI-CENTER, NON-INFERIORITY IMMUNOGENICITY AND SAFETY STUDY OF TWO FORMULATIONS OF GSK BIOLOGICALS¿ MENINGOCOCCAL ACWY CONJUGATE VACCINE

Registry ID

205343

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

GLAXOSMITHKLINE INC

Start date

2018-09-10

Last update

2018-06-14

Conditions

• MENINGITIS

Related clinical trials

• A PHASE IIIB, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO EVALUATE SAFETY AND IMMUNOGENICITY OF GSK¿S MENINGOCOCCAL ABCWY VACCINE WHEN ADMINISTERED IN HEALTHY ADOLESCENTS AND ADULTS, PREVIOUSLY PRIMED WITH MENINGOCOCCAL ACWY VACCINE

View on source registry